Cite

    Porter, J., Bowden, D. K., Economou, M., Troncy, J., Ganser, A., Habr, D., Martin, N., Gater, A., Rofail, D., Abetz-Webb, L., Lau, H., & Cappellini, M. D. (2012). health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial. Anemia, 2012, . http://access.bl.uk/ark:/81055/vdc_100082155242.0x00001b